We and our partners share similar ideals, values and purposes for our existence and establishments. We see our partners as our business partners, stakeholders and family. We, therefore, strive to be dependable, accountable and resourceful to our partners through uncompromised professionalism and compassion.
Biotechnology is a frontline area of science with immense potential for the benefit of humankind. Borne out of the Cradle of Humankind (Africa), our company is a pioneering biotech firm that was established in South Africa as a research project in 2015.
In 2018, we launched Capebio™ Technologies (Capebio™SA) as a 100% privately owned company.
At Capebio™SA, we mine microbial data from unique African microbial ecosystems in search of genetic material that codes for novel biomolecules (e.g., enzymes, proteins and peptides).
We use OUR PROPRIETARY ARTIFICIAL INTELLIGENCE PLATFORM to discover and develop these molecules with precision, acceleration and sureness before downstream developmental processes.
To develop the “best-in-class” healthcare solutions in Africa, for Africa and the world.
To create excellent innovations that improve the quality of life in Africa and beyond.
Integrity, Accountability, Responsible Innovation, Diversity, and Inclusion.
Media & News
Over the last 5 years, we have been making headlines for the right reasons. Our innovative capabilities have not only put us on the global stage but have raised awareness of the scientific talent that South Africa possesses. We have learned a lot from this journey, and we believe we will be able to do even much better going forward. We have demonstrated many times all our core values and were at the heart of Southern Africa’s response to the COVID-19 Pandemic, by rapidly deploying our talent and technology to launch regulatory-approved PCR In Vitro diagnostic (IVD) tests. We strongly believe that we will deliver on our long-term courageous commitment in ensuring that our innovations impact ordinary lives beyond Southern African shores.